COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

 


Course Description

The goal of this live, virtual event, is to foster the continuous improvement in mental health care through the delivery of educational content featuring leading experts discussing the latest advances in psychiatric treatments.  Content will be clinically focused, but based in the latest evidence-based practice and research.  Topics will include novel treatments for depression, with a focus on neuromodulation and psychedelic agents.

The target audience for this initiative includes clinical UC San Diego faculty, community psychiatrists, psychologists, NP/PA’s, and program alumni.

Educational Objectives

At the completion of this activity, participants should be able to:

  • Describe novel treatments for depression and appropriate usage for each treatment option 
  • Discuss neuromodulation and psychedelic treatments for major depression
  • Make informed decisions regarding selection of treatment options, including neuromodulation and psychedelics, for patients with major depression  

Agenda

Friday, September 30, 2022

​8:00am – 8:15am 
Welcome and Introductory Remarks, Gregory Light, PhD (UCSD) & Steven F. Huege, MD (UCSD)
​8:15am – 9:15am
​Psychedelics and Depression, David Nutt, DM, FRCP, FRCPsych, FSB, FMedSci (Imperial College London)
​9:15am – 10:15am
Magnetic Seizure Therapy,  Zafiris "Jeff" Daskalakis, MD, PhD, FRCP (UCSD)
​10:15am
Break
​10:30am – 11:30am
Ketamine and Depression, John Krystal, MD (Yale)
​11:30 am – 12:30pm
​Transcranial Magnetic Stimulation (TMS), Nolan Williams, MD (Stanford)
12:30pm – 1:15pm
Meet the Experts
​1:15pm
Final Adjournment


UC San Diego Course Directors

William B. Schoolcraft, MD, HCLD
Steven F. Huege, MD, MSEd

Program Director, UCSD Geriatric Psychiatry Fellowship
Clinical Professor 
Department of Psychiatry
UC San Diego School of Medicine
La Jolla, California

Antonio Pellicer, MD

Gregory Light, PhD 
Professor & Vice Chair
Department of Psychiatry - Education & Training
UC San Diego School of Medicine
Director, VA San Diego MIRECC
Co-Director VA San Diego Mental Health Research
La Jolla, California

Presenting Faculty

Michel Abou Abdallah, MD

Zafiris "Jeff" Daskalakis, MD, PhD, FRCP
Chair, Department of Psychiatry
UC San Diego School of Medicine
La Jolla, California

Diana Alecsandru, MD, PhD

John Krystal, MD
Robert L. McNeil, Jr. Professor of Translational Research
Professor (Psychiatry, Neuroscience, and Psychology)
Co-Director, Yale Center for Clinical Investigation
Chair, Department of Psychiatry
Yale School of Medicine
Chief of Psychiatry, Yale-New Haven Hospital
Director, NIAAA Center for the Translational Neuroscience of Alcoholism
Director, Clinical Neuroscience Division, VA National Center for PTSD
New Haven, Connecticut

Oladapo Ashiru, MD, PhD

David Nutt, DM, FRCP, FRCPsych, FSB, FMedSci
Edmond J Safra Chair in Neuropsychopharmacology
Director, Neuropsychopharmacology Unit
Division of Brain Sciences
Imperial College London
South Kensington Campus, London

Charles L. Bormann, PhD, HCLD

Nolan Williams, MD
Assistant Professor
Department of Psychiatry and Behavioral Sciences
Director, Stanford Brain Stimulation Lab
Stanford University
Stanford, California

Registration

 Register Online

On or Before July 30, 2022

On or After July 31, 2022

MD / DO
$195
​$225
​PhD / PsyD
​$140
​$150
Allied Health Professionals
$140
​$150
Trainee
​$125
​$125
​UC San Diego Alumni
​$175
​$175
SD / Orange County Psychiatric Society Member
$175
$175


Online registration closes Wednesday, September 28, 2022

Cancellation Policy: The full course tuition is refundable, less $50 if your cancellation is received in writing, on or before September 20, 2022. No refunds will be allowed after this date.
In the unlikely event that the course is canceled, UC San Diego is responsible only for a full refund of the registration fee.

The activity syllabus will be available electronically. The full course syllabus as well as any missing presentations will be available for download on the conference website approximately (1) one week after the conference. UC San Diego Continuing Medical Education (CME) is committed to creating a healthy and sustainable environment. 

Accreditation

The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.75 hours of Category 1 credit for completing this program.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 4.75 hours of credit and list CME Category 1" as the provider number).

The UCSD Eating Disorders Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The UCSD Eating Disorders Center maintains responsibility for this program and its content.

Disclosure Statement: It is the policy of University of California San Diego Continuing Medical Education to ensure that the content of accredited continuing education and related materials is accurate, balanced, objective, and scientifically justified. Education must be free of the influence or control of ineligible companies, and protect learners from promotion, marketing, and commercial bias.  All persons in a position to control the content of accredited education must disclose all financial relationships held with ineligible companies, prior to assuming a role in the activity. Those relationships deemed relevant to the education, are mitigated prior to the activity through one of the following strategies: 1) divesting the financial relationship, 2) altering the individual’s control over content, and/or 3) validating the content through independent peer review. Persons who refuse or fail to disclose are disqualified from participating in the activity. Activities are evaluated by participants and peer reviewers to determine if the content was free of bias and met acceptable scientific standards. This information is considered in future activity planning. 

Contact Us

UC San Diego School of Medicine
Continuing Medical Education
9500 Gilman Drive, MC0947
La Jolla, CA 92093-0947
Phone: (858) 534-3940 or (888) 229-6263
Fax: (858) 534-1896
ocme@health.ucsd.edu

Jennifer Fruehauf
Program Manager
jachsel@health.ucsd.edu

Bermellyn N. Imamura, CMP
Program Manager
bimamura@health.ucsd.edu

Show additional content areas below